| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | $1.5B | $1.4B | $1.5B | $1.5B | $1.3B | $0.9B | $1.0B | $1.1B |
| Gross Profit | $0.9B | $0.8B | $0.9B | $1.0B | $0.2B | $0.1B | $0.1B | $0.2B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.4B | $0.4B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B | $0.3B |
| Operating Income | $0.0B | $0.2B | $0.4B | $0.5B | $0.1B | $0.1B | $0.0B | $0.1B |
| Net Income | $-0.1B | $0.1B | $0.3B | $0.4B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $-2.89 | $4.04 | $10.44 | $15.09 | $2.11 | $2.41 | $5.66 | $6.62 |
| EPS (Diluted) | $-2.89 | $4.00 | $10.34 | $14.94 | $2.08 | $2.39 | $5.60 | $6.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.0B | $3.9B | $4.0B | $3.9B | $3.2B | $2.7B | $2.6B | $2.6B |
| Current Assets | $1.4B | $1.6B | $1.4B | $1.5B | $1.3B | $1.2B | $1.0B | $1.0B |
| Cash & Equivalents | $0.6B | $0.7B | $0.6B | $0.6B | $0.5B | $0.7B | $0.5B | $0.5B |
| Total Liabilities | $1.5B | $1.5B | $1.5B | — | — | — | — | — |
| Current Liabilities | $0.5B | $0.4B | $0.4B | $0.6B | $0.4B | $0.3B | $0.2B | $0.3B |
| Stockholders' Equity | $2.4B | $2.4B | $2.5B | $2.2B | $1.9B | $1.6B | $1.5B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B | $0.3B |
| Investing Cash Flow | $-0.5B | $-0.1B | $-0.3B | $-0.6B | $-0.5B | $-0.1B | $-0.1B | $-0.4B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.1B | $-0.1B | $-0.2B | $0.3B | $-0.1B | $-0.1B | $-0.1B | $0.1B |